GILD
Price:
$123.76
Market Cap:
$153.66B
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vo...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1992-01-22
Stock Exchange
NASDAQ
Ticker
GILD
According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 168.20B. This represents a change of 0.34% compared to the average of 167.63B of the last 4 quarters.
The mean historical Enterprise Value of Gilead Sciences, Inc. over the last ten years is 118.00B. The current 168.20B Enterprise Value has changed 14.15% with respect to the historical average. Over the past ten years (40 quarters), GILD's Enterprise Value was at its highest in in the March 2026 quarter at 187.64B. The Enterprise Value was at its lowest in in the December 2018 quarter at 90.07B.
Average
118.00B
Median
116.80B
Minimum
90.57B
Maximum
169.72B
Discovering the peaks and valleys of Gilead Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 28.67%
Maximum Annual Enterprise Value = 169.72B
Minimum Annual Increase = -27.55%
Minimum Annual Enterprise Value = 90.57B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 169.72B | 28.67% |
| 2024 | 131.91B | 9.92% |
| 2023 | 120.00B | -5.92% |
| 2022 | 127.56B | 13.33% |
| 2021 | 112.56B | 14.11% |
| 2020 | 98.64B | 3.30% |
| 2019 | 95.49B | 5.43% |
| 2018 | 90.57B | -24.26% |
| 2017 | 119.59B | 4.90% |
| 2016 | 114.00B | -27.55% |
The current Enterprise Value of Gilead Sciences, Inc. (GILD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
140.54B
5-year avg
132.35B
10-year avg
118.00B
Gilead Sciences, Inc.’s Enterprise Value is less than Pfizer Inc. (206.49B), less than Amgen Inc. (227.49B), greater than Sanofi (103.60B), greater than Bristol-Myers Squibb Company (145.16B), greater than GSK plc (92.78B), less than Merck & Co., Inc. (325.03B), greater than Danaher Corporation (138.18B), greater than Boston Scientific Corporation (76.82B), less than Novo Nordisk A/S (1.43T), greater than Stryker Corporation (130.35B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 206.49B | $143.74B | |
| 227.49B | $182.21B | |
| 103.60B | $101.89B | |
| 145.16B | $110.27B | |
| 92.78B | $101.54B | |
| 325.03B | $281.24B | |
| 138.18B | $125.40B | |
| 76.82B | $67.32B | |
| 1.43T | $191.93B | |
| 130.35B | $118.00B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Gilead Sciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Gilead Sciences, Inc. (GILD)?
What is the 3-year average Enterprise Value for Gilead Sciences, Inc. (GILD)?
What is the 5-year average Enterprise Value for Gilead Sciences, Inc. (GILD)?
How does the current Enterprise Value for Gilead Sciences, Inc. (GILD) compare to its historical average?